At Close: 4:00 PM
AnaptysBio Stock Price Graph
AnaptysBio Stock Price Today
AnaptysBio, Inc. (ANAB) stock declined over -0.36% intraday to trade at $13.85 a share on NASDAQ. The stock opened with a gain of 21.44% at $16.88 and touched an intraday high of $17.25, falling -0.36% against the last close of $13.90. The AnaptysBio, Inc. in stock market went to a low of $16.14 during the session.
AnaptysBio Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
AnaptysBio Stock Price History Chart
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Frequently Asked Questions
What is the current AnaptysBio, Inc. (ANAB) stock price?
AnaptysBio, Inc. (NASDAQ: ANAB) stock price is $13.85 in the last trading session. During the trading session, ANAB stock reached the peak price of $17.25 while $16.14 was the lowest point it dropped to. The percentage change in ANAB stock occurred in the recent session was -0.36% while the dollar amount for the price change in ANAB stock was -$0.05.
ANAB's industry and sector of operation?
The NASDAQ listed ANAB is part of Biotechnology industry that operates in the broader Healthcare sector. AnaptysBio, Inc. , a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications.
Who are the executives of ANAB?
Mr. Benjamin Stone
Senior Vice President of Corporation Devel.
Ms. Beth Mueller
Senior Vice President of HR
Mr. Daniel R. Faga
Interim Pres & Chief Executive Officer and Director
Mr. Eric J. Loumeau
Chief Operating Officer & Gen. Counsel
How ANAB did perform over past 52-week?
ANAB's closing price is 0.16% higher than its 52-week low of $16.135 where as its distance from 52-week high of $32.435 is -0.35%.
How many employees does ANAB have?
Number of ANAB employees currently stands at N/A. ANAB operates from 10770 Wateridge Circle, San Diego, CA 92121-5801, US.
Link for ANAB official website?
Official Website of ANAB is: https://www.anaptysbio.com
How do I contact ANAB?
How many shares of ANAB are traded daily?
ANAB stock volume for the day was 176007.00 shares. The average number of ANAB shares traded daily for last 3 months was 234.68 Thousands.
What is the market cap of ANAB currently?
The market value of ANAB currently stands at $368.13 Million with its latest stock price at $13.85 and N/A of its shares outstanding.